Financial PerformanceKRMD delivered a strong quarter as it beat on revenue and margin expectations, seeing material outperformance in its OUS markets.
Growth OpportunitiesKRMD raised its revenue guidance reflecting growth of now 15-17%, underpinned by SCIg market growth, global share gains, NRE revenue from new expected collaborations, flow controller line extension, and Japan market entry.
Product InnovationThe new product initiative is focused on an easier-to-use and more comfortable pump and disposable infusion set.